fda and tirzepatide says the weight-loss drug shortage is over FDA Approves Tirzepatide (Zepbound) as

The dose escalation schedule typically looks like this: weeks 14 involve the starter dose, weeks 58 involve the intermediate dose, and weeks 9 onward allow for fine-tuning based on your response and tolerability

In line with this observation, our laboratory found that a brain infusion of exendin-9, an antagonist of the GLP-1 receptor, can reduce muscle glucose utilization and its storage as glycogen in mice receiving glucose from an intragastric catheter [70]

This begs the question: Why do computations show that GSH relatively independent of in the model, despite glutathione being downstream of MS activity

PMID: 17163101

Important Note: Pregnant individuals should avoid taking any weight loss drugs, including fat blockers or appetite suppressants